Biotech | November 12, 2021
Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
_256_384.png)
Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
Subscribe To Our Newsletter & Stay Updated
